Literature DB >> 14724370

Endothelial nitric oxide synthase expression in systemic and pulmonary circulation of streptozotocin induced diabetic rats: comparison using image analysis.

P Sridulyakul1, D Chakraphan, P Bhattarakosol, S Patumraj.   

Abstract

To compare the level of endothelial nitric oxide synthase (eNOS) expression produced in heart and lung vascular tissue, the protein content was determined using Western blot analysis with the enhancement of image processing. Heart and lung extracts from 12 and 24 weeks from control (CON) and streptozotocin-induced diabetic (DM) rats were collected for Western blot analysis. Using monoclonal antibody against rat eNOS protein (140 kDa), the eNOS-protein bands were detected with enhanced chemiluminescence (ECL; Amersham) and exposured to film (Hyperfilm-ECL; Amersham). Images of eNOS bands on each film were then scanned and saved to digital files. Using Global Lab Image software, the number of pixels in each digital file was counted and calibrated for eNOS-protein content. For the CON and DM groups, the mean values of eNOS-protein contents were calculated and expressed as a percentage of total protein content, 5 micrograms. It was found that the eNOS level in DM hearts was significantly decreased, as compared to age-matched CON hearts. On the other hand, eNOS levels in DM lungs was increased, compared to CON lungs. Therefore, it may be concluded that high, not low, flow-mediated eNOS expression is a good measure of hyperglycemic-induced endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14724370

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  7 in total

1.  Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation.

Authors:  Jason M Konter; Jennifer L Parker; Elizabeth Baez; Stephanie Z Li; Barbara Ranscht; Martin Denzel; Frederic F Little; Kazuto Nakamura; Noriyuki Ouchi; Alan Fine; Kenneth Walsh; Ross S Summer
Journal:  J Immunol       Date:  2011-12-07       Impact factor: 5.422

2.  Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling.

Authors:  Guochuan Ma; Mohamed Al-Shabrawey; John A Johnson; Rahul Datar; Huda E Tawfik; Dehuang Guo; Ruth B Caldwell; R William Caldwell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-06       Impact factor: 3.000

3.  Correlations between Endothelial Functions and ROS Detection in Diabetic Microvascular Wall: Early and Late Ascorbic Acid Supplementation.

Authors:  Pattarin Sridulyakul; Natchaya Wongeak-In; Suthiluk Patumraj
Journal:  Int J Vasc Med       Date:  2012-05-28

4.  Effect of aerobic exercise training on regional blood flow and vascular resistance in diabetic rats.

Authors:  Sarah Cristina Ferreira Freitas; Ângela d'Avila Harthmann; Bruno Rodrigues; Maria-Cláudia Irigoyen; Kátia De Angelis
Journal:  Diabetol Metab Syndr       Date:  2015-12-21       Impact factor: 3.320

5.  Cobalt Chloride Upregulates Impaired HIF-1α Expression to Restore Sevoflurane Post-conditioning-Dependent Myocardial Protection in Diabetic Rats.

Authors:  Jianjiang Wu; Long Yang; Peng Xie; Jin Yu; Tian Yu; Haiying Wang; Yiliyaer Maimaitili; Jiang Wang; Haiping Ma; Yining Yang; Hong Zheng
Journal:  Front Physiol       Date:  2017-06-13       Impact factor: 4.566

6.  Response of cardiac endothelial nitric oxide synthase to plasma viscosity modulation in acute isovolemic hemodilution.

Authors:  Kanyanatt Kanokwiroon; Surapong Chatpun
Journal:  Asian J Transfus Sci       Date:  2014-07

7.  Comparison of Pulmonary and Systemic NO- and PGI2-Dependent Endothelial Function in Diabetic Mice.

Authors:  Andrzej Fedorowicz; Elżbieta Buczek; Łukasz Mateuszuk; Elzbieta Czarnowska; Barbara Sitek; Agnieszka Jasztal; Antonina Chmura-Skirlińska; Mobin Dib; Sebastian Steven; Andreas Daiber; Stefan Chlopicki
Journal:  Oxid Med Cell Longev       Date:  2018-06-04       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.